Several novel sealing materials have been proposed as an adjunct to sutured dural closure to help insure watertight closure, thus diminishing the risk of pseudomeningocele formation. This evaluation was undertaken to clarify the in vivo magnetic resonance imaging (MRI) and computed tomographic (CT) scan characteristics of one such sealant, which has a high water content, permitting similar imaging characteristics to pseudomeningoceles and inflammatory collections. METHODS: After a craniotomy in two canine subjects, we sprayed a novel, watersoluble, self-polymerizing, absorbable, hydrogel sealant onto the dura and the bone flap was replaced. After recovery, both animals underwent MRI and CT scans after 3 days and again at 2, 4, 6, 8, and 10 weeks after the craniotomy. The appearance of the gel at each timepoint was characterized and compared with the macroscopic and microscopic findings obtained 14 weeks after implantation. RESULTS: Both animals remained neurologically intact. Hydrogel sealant was readily apparent with all imaging techniques through Week 6. Diagnostic distinction from inflammatory collections and pseudomeningoceles was possible with MRI, using inversion recovery and contrast-enhanced sequences; such distinctions were occasionally challenging with a contrast-enhanced CT scan. Temporal absorption of the gel and subsequent closure of the remaining void was documented. Histopathology showed minimal changes, and excellent tissue compatibility of the gel was noted. CONCLUSION: The hydrogel sealant can be observed with cross sectional imaging and can be distinguished from cerebrospinal fluid using a CT scan, complemented by an occasional MRI scan. In addition, complete absorption of the hydrogel, with closure of the remaining void was noted. Histological examination found an unremarkable response with no neurotoxicity or space-filling defect.
O
ne ubiquitous neurosurgical problem is cerebrospinal fluid (CSF) leakage after dural closure. Existing methods of dural closure and dural augmentation are associated with some morbidity or with a high level of complexity of use. The need for a safe, effective, and easy-to-use tissue-compatible sealant for dural closure augmentation is widely recognized. Such a substance should prevent adhesion formation, provide a surface for neodura generation, and be safely resorbed after it has served its purpose.
Many substances have been used for dural closure, with varying degrees of success and levels of complication. Beyond the use of sutures, in efforts to ensure dural closure surgeons have used titanium clips, cyanoacrylates (fibrin glue), albumin-based compounds (glutaraldehyde glues), autografts (e.g., fat tissue, fascial membrane, pericranial grafts, fascia lata, and abdominal wall fascia), allografts (e.g., amniotic and placental membranes, pericardium, fascia from various sources, lyophilized dura, and bilayered collagen substitutes, such as placental collagen), xenografts (e.g., bovine or porcine pericardium, peritoneum dermis, and flexor tendons), synthetic materi-als (e.g., expanded polytetrafluoroethylene, polyester silicon, and polyester urethane nonresorbable microporous fleece), and laser thermocoagulation.
Recently, a new synthetic hydrogel, DuraSeal Dural Sealant (Confluent Surgical, Inc., Waltham, MA), was shown to effectively seal dura in a canine cranial sealing model (17) . Preul et al. (17) characterized the behavior of this material after dural application in a clinically relevant model. Our report describes the appearance of the sealant at different times, as the sealant is absorbed and the remaining void is closed. The sealant is not intended to be a dural substitute, but, rather, is intended to provide a watertight seal while the underlying dura heals.
With the advent of next-generation dural sealants, such as DuraSeal, understanding the appearance of the dural sealants under conventional radiological imaging methods is critical to appropriate clinical evaluation and use. Other exogenous substances, such as oxidized cellulose, have the potential to be mistaken for a postoperative abscess and, thus, have been well characterized under magnetic resonance imaging (MRI) and computed tomographic (CT) imaging (16, 27) . Characterization of the appearance of the sealant will reduce the possibility of misdiagnoses during radiological assessment.
MATERIALS AND METHODS

Hydrogel Sealant
The evaluated sealant, DuraSeal Dural Sealant, is a water soluble, synthetic polyethylene glycol (PEG)-based sealant, which transforms from a liquid to a solid within 2 seconds of spraying onto tissue ( Fig. 1) , without detectable heat generation. The resulting hydrogel sealant is more than 90% water, with dilute Food, Drug, and Cosmetic Blue #1 dye added to allow for accurate estimation of coverage and thickness (Fig. 2) . This dye is not bound into the hydrogel network; the dye diffuses from the sealant within hours of implantation and is cleared by the kidneys.
The flexible hydrogel sealant is tissue adherent and is designed to withstand CSF pressures while the dura heals. After 1 to 2 months, hydrolyzable linkages within the PEG backbone allow the sealant to break down, absorb, and undergo renal clearance (19, 26) .
Surgical Procedure
Two male beagles (mean weight, 16.7 kg) were used for the experiment, in compliance with the Harvard Medical School Institutional Animal Care and Use Committee rules and regulations. Surgical procedures were conducted using routine sterile techniques. Animals were sedated with a cocktail of xylazine, atropine, and ketamine. The animals were intubated and anesthesia was maintained with inhalant isoflurane. A curvilinear incision was made in the right frontoparietal region. The temporalis muscle was reflected laterally, three burr holes were created, and a triangular-shaped bone flap was raised with a Gigli saw. The dura was not incised in this study. After the confirmation of hemostasis, we applied the hydrogel sealant to the dural surface, to a gel thickness of 3 mm, approximately the same thickness as the bone flap (Fig. 2) . The bone flap was replaced over the sealant and secured using 2-0 Vicryl sutures. The overlying muscle and skin were separately sutured and closed. Animals were returned to their cages for recovery, where they had free access to food and water.
Imaging
At 3 days and at 2, 4, 6, 8, and 10 weeks after implantation, the animals were anesthetized as described above, under Surgical Procedure (mean duration of anesthesia, 2.5 h), using an MRI-compatible animal anesthesia machine (SurgiVet, Waukesha, WI). Animals were positioned in dorsal recumbency, head first, in both the CT and MRI scanners, and imaged with both modalities, in close temporal succession.
CT Scan Protocol
CT imaging was performed on a Somatom Plus 4 (Siemens AG, Erlangen, Germany). Images were acquired with a continuous spiral acquisition from C1 to the vertex (0 gantry tilt; standard algorithm with 2.5-mm slice thickness and spacing; table feed, 3.75 mm/s; 3:1 pitch with high quality mode; 140 kV; 170 mA; 1 s rotation time; and a 20-cm field of view). Images were reconstructed with soft tissue and brain algorithms and windows.
MRI Protocol
MRI scans were acquired on a 1.5-T CV/iMRI scanner (General Electric Healthcare, Milwaukee, WI) using a receiveonly 6-inch surface coil. T2-weighted; fluid-attenuated inversion recovery (FLAIR); precontrast T1-weighted; and postcontrast T1-weighted images were acquired in the axial and coronal planes. In-plane resolution was 0.7 ϫ 0.75 mm 2 dose of 2 mL gadolinium diethylenetriamine penta-acetic acid (Magnevist; Berlex Labs, Wayne, NJ) was administered 5 minutes before postcontrast T1-weighted imaging. The complete protocol is shown in Table 1 .
Histopathology
Fourteen weeks after implantation, the canines were killed, according to institutional guidelines, and the intact brains and skulls were fixed with formalin. After complete fixation, the brain, dura, and bone flap were removed en bloc, and transverse sections were made in the same coronal plane used for imaging in the in-life phase of this study. Transverse sections were decalcified and further trimmed, such that each section contained the implant site, the bone flap, and approximately 1 cm of adjacent bone and tissue. Each transverse section was infiltrated and embedded in paraffin, sectioned at 7 m, and stained with hematoxylin and eosin. Sections were interpreted by a qualified veterinary pathologist.
RESULTS
Both animals survived the surgical procedures and were neurologically intact. Both animals remained healthy throughout the entire postoperative period.
Image Interpretation
Images were obtained from both animals, and findings at all time points were similar between the two animals. Representative images from each imaged time point from one animal are shown (Fig.   3 ). The images can be analyzed with respect to the appearance of the skull, the cortex, the hydrogel, and the contrast enhancement. Among the helpful MRI scans demonstrating the presence of the hydrogel and characterizing the surrounding tissues, were the FLAIR images, which showed the gel as a homogeneous and separate signal intensity from the CSF. The postcontrast T1-weighted images were helpful in demonstrating the symmetric reactive enhancement surrounding the hydrogel. Similarly, the CT scans demonstrated a similar enhancement pattern to that observed in the postcontrast T1-weighted images, because of the reactive tissue enhancement. Moreover, the CT scans showed the presence of the hydrogel, with the same sensitivity as the FLAIR images, although not as well as the postcontrast T1-weighted images. With the 3-day time point as a baseline, the temporal evolution of the hydrogel appearance can be described.
Week 1
The hydrogel was isointense with respect to the cortex in FLAIR images. Subtle streak-like hyperintensities, possibly representing blood products, were noted in the hydrogel in the postcontrast T1-weighted images. Contrast enhancement was clearly observed between the hydrogel and the brain. Slight adjoining cortical surface enhancement was appreciated on the CT images. Slight cortical displacement secondary to hydrogel-related mass effect was also observed.
Week 2
MRI sequences showed that the hydrogel further increased in thickness since the first imaging time point, and the surface adjoining the cortex appeared smoother. The T1-weighted postcontrast images demonstrated enhancement between the hydrogel and cortex, and new enhancement between the hydrogel and the calvarium. CT images also exhibited increased hydrogel volume, with enhancement appreciated between the hydrogel and cortex. It was not easy to appreciate enhancement adjacent to the hyper-attenuating calvarium on the CT images; enhancement at this site was more clearly shown on the MRI scans. The hydrogel was most conspicuous on the T2-weighted and postcontrast T1-weighted images.
Week 4
The greatest interval reduction in hydrogel thickness was noted in this 2-week interval scan set (between Week 2 and Week 4), with a large amount of interval absorption observed compared with Week 2 images. On FLAIR images, there was a new hyperintense portion of the hydrogel adjacent to the cortex, which was difficult to distinguish from the enhancing tissue observed on postcontrast T1-weighted images.
Week 6
CT and FLAIR images appeared essentially normal, suggesting full absorption of the hydrogel. However, T2-weighted and postcontrast T1-weighted images demonstrated residual hydrogel persistence, and bed enhancement was observed on the postcontrast T1-weighted images.
Week 8
The CT changes implying the presence of the hydrogel were no longer appreciable. The cortex had moved into its normal position. Beam hardening obscured fine juxtacalvarial detail. On T2-weighted images, extra-axial hydrogel was still observed. Residual bed T1-weighted contrast enhancement was still observed.
Week 10
T1-weighted images demonstrated absorption of the hydrogel since Week 8. This change was demonstrated with a greater confidence than afforded with the T2-weighted images, which may be limited juxtacalvarially by susceptibility effects. Very subtle contrast enhancement of the hydrogel bed at 10 weeks was observed on postcontrast T1-weighted images.
Histopathology
The cut edges of the bone flap were identified as fullthickness perpendicular interruptions in the skull. The space between the bone flap and the cranium was filled by mature fibrous tissue that merged with the periosteum lining the surface of the bone flap and adjacent bone, and extended to and merged with the overlying soft tissue. The subperiosteal bone of the bone flap had undergone limited remodeling, and there was no evidence of osteolysis. The alterations noted in the bone flap and adjacent bones were appropriate for the interval after implantation (Fig. 4) .
The dura mater underlying the bone flap, as a whole, was slightly thickened as compared with the dura mater beyond the margins of the bone flap. The thickening was variable, ranging from approximately 100 to 400 m. The slight increased thickness of the dura mater was attributed to increased fibrous tissue and was greatest where the dura adjoined the cut edges of the bone flap. The cellular density of the fibrous tissue associated with the expanded dura mater under the bone flap was equivalent to that located outside of the defect. Inflammatory cells were limited to two small, elongated aggregates of foamy macrophages located at both cut edges of the bone flap. No other inflammatory cells or inflammatory cell aggregates were noted. No sealant material was observed in any of the tissue sections examined, supporting the full absorption that was suspected from the imaging studies.
When the bone flap was removed during surgery in one of the animals (animal 13012) the dura split, with part of the dura remaining with the bone flap. The sealant was applied to the remaining dura, and, after replacement of the bone flap, the sealant kept the dural surfaces separate while they healed. Microscopically, the separation in the dura mater was still evident (Fig. 5) . Effectively, the presence of the sealant prevented scar formation between the dura attached to the bone flap and the underlying dura. No separations in the dura mater were noted in the bone adjacent to the bone flap.
The dura mater was not attached to, nor did it impinge on, the pia mater. The underlying cerebrum was normal, with no evidence of toxicity or inflammation. The outline of the cerebrum was normal, with no compressive alteration or evidence of local mass effect.
DISCUSSION
The described sealant, DuraSeal Dural Sealant, demonstrates several hypothetically favorable properties: it is nontoxic, is biocompatible, and does not cause inflammation or result in extension adhesions to the underlying brain; it is easily prepared, stable at room temperatures, and easy to apply; it has sufficient tensile strength to withstand intracranial CSF pressure during valsalva; it is able to bridge dural gaps of up to 2 mm, and it is absorbed after neodura formation.
The properties of the dural sealant become compelling when considering the landscape of rival techniques for dural closure and, alternatively, duraplasty. Fibrin glues are often used to augment dural closures, although their actual efficacy is unknown (12) . Drawbacks of fibrin glue include difficult preparation, limited clot strength, poor tissue adherence, inflammation, and concerns regarding immunogenicity, viral transmission, and an unknown efficacy (20, 23) . Laser thermocoagulation-reinforced suture closure achieves a leakfree closure with a high tensile strength (6), but requires the purchase of capital equipment and the appropriate certification. Complications associated with duraplasty include inflammation, infection, and foreign body response (4, 18); hematoma (1, 3, 9, 15, 21); proliferative fibrosis (13); transmission of disease from cadaveric preparations (5, 10, 11, 14, 22) ; and, with the use of retained sutures, meningeal adhesions (8) . Autografts are subject to hypoxia, which can evoke adhesions and inflammatory responses (2) . The preparation of a second surgical site is subject to morbidity. Allografts also carry the risk of transmitting infection (5) and adhesions caused by immune-mediated response (2) . Xenograft use enjoys a lesser risk of infectious transmission but carries a greater risk of immunogenic response. Synthetic materials and immunologically inert substances, such as acellular human dermis (24) require preparation and cannot completely approximate the characteristic of dura; moreover, they are secured with sutures, requiring additional punctures of the dura. In contrast, the hydrogel used in this study offers the advantages of ease of preparation (no need for cutting to shape, no second surgical site) and use (substance is tissue compliant, and the dye provides visual feedback for adequate application); presents no additional demonstrable risk of foreign-body response or transmission of disease; and is completely resorbed.
Clinically, on the basis of the appearance of the hydrogel, there may be a question of imaging characteristics overlapping with a persistent unilocular fluid collection, such as a pseudomeningocele, or, of greater concern, hypothetically, the imaging characteristics can overlap with an infected surgical bed or an inflammatory fluid collection.
Imaging
The hydrogel is easily visualized with both CT scans and MRI, from instillation through the 4-week imaging interval, and the hydrogel becomes progressively more difficult to visualize from Weeks 6 to 10. By 10 weeks after implantation, it is very difficult to appreciate any residual hydrogel. The greatest confidence in visualizing the hydrogel is afforded with T2-weighted and postcontrast T1-weighted MRI.
In terms of the temporal changes demonstrated with the hydrogel, conspicuous changes in the volume of the hydrogel, and changes in the signal and enhancement characteristics of the hydrogel bed take place. Slight swelling of the hydrogel between Day 3 and Week 2 were observed, simultaneous with development of increasing superficial and deep adjoining circumferential enhancement; maximum hydrogel-adjoining enhancement was observed at Week 2. The central portion of the hydrogel was not enhanced, only the periphery of the hydrogel showed a shell-like rim of enhancement. The greatest change in volume took place between Weeks 2 and 4, with rapid resorption of the hydrogel, simultaneous with a reduction in the enhancement intensity of the margins. From this time point, there was a gradual ongoing reduction in the volume of hydrogel and a reduction in the conspicuity of the hydrogel-adjoining enhancement, until the 10-week time point, by which time, there was nearly total resorption of the hydrogel, with virtually no residual enhancement.
FLAIR imaging should be useful in differentiating the hydrogel from a pseudomeningocele. The hydrogel collection is hyperintense to CSF found in an uncomplicated pseudomeningocele, thus, in terms of signal characteristics, paralleling gray matter more closely than CSF.
Alternatively, the concerns regarding an inflammatory collection or an infection are best appreciated with T1-weighted MRI. An infected collection would have greater signal heterogeneity than that shown on the circumferentially and marginally enhancing noninfected implanted hydrogel images. Therefore, the symmetric and homogeneous circumferential marginal enhancement, which is especially exuberant in the first 2 weeks after craniotomy, should be helpful in differentiating the adjoining implanted hydrogel from an infected surgical bed.
Similarly, with an uncomplicated uninterrupted singlesheet hydrogel implant, there should be no enhancing transhydrogel bands or central hydrogel enhancement. In the event that MRI and CT scans are unable to confidently exclude infection, an indium-labeled white blood cell nuclear medicine study may need to be considered. Alternatively, diffusionweighted MRI has also been shown to assist in the diagnosis of subdural empyemas by demonstrating hyperintensity in empyema collections, and, in certain cases, has helped in differentiating inflammatory collections from neoplasms (7, 25) . Although the diffusion characteristics of the gel were not investigated in the scope of this work, it will be assessed in future clinical trials. Regarding the role of CT scanning in characterizing the hydrogel collections, it is reassuring to observe the similarity in the hydrogel volume changes and enhancement characteristics adjoining the hydrogel implants when comparing the CT studies with the MRI studies. Nevertheless, because questions regarding fluid collections and inflammation or infection may arise, if chronological growth of the hydrogel bed beyond 2 weeks is observed, or if there is complex central hydrogel enhancement or enhancement shown increasing in intensity beyond the 2-week timepoint, MRI examination may be necessary to further characterize the bed. In the exceptionally rare instances in which further investigation may be warranted beyond MRI, indium-labeled white blood cell nuclear medicine scanning should be considered.
Histopathology
Unlike many craniotomy procedures, in which subcraniotomy tissues may be resected or removed, no subdural tissue was removed during the procedures in the current study. As observed in the images, this resulted in some cortical displacement to accommodate the sealant volume. As observed 8 weeks after implantation, the cortex moved into its normal position after the hydrogel was adsorbed. Histopathological examination of both animals found no signs of neurotoxicity, no cortical compression, and no signs of a local mass effect. This suggests that, in this model, arguably a worst-case scenario with no subdural tissue removal and a small canine cranial vault, there were no lasting effects of the transient compression that was observed in imaging.
The separation observed between the bone flap and dura mater was not an artifact of processing, as evident by the slightly more-cellular smooth layer of elongate fibroblasts lining both margins of the separation; the palisading orientation of the adjacent fibroblasts; and the absence of tissue tearing, such as fraying of the fibrous tissue, which would indicate artificial separation. For re-exploration of the site, these attachments could be easily incised or broken. The test article acted as a semi-inert, space-filling mass, preventing attachment of the dura to the bone flap, such as would normally form after a craniotomy. As the hydrogel was absorbed, the tissue response did not induce the formation of fibrous bands between the bone flap and the dura. Scar formation between the bone flap and the underlying dura after surgery can lead to complications and can result in additional surgical time in reoperations. Separating the dura from the bone flap can result in additional injury, tears, or undesired bleeding. Although this study was not powered to demonstrate this effect, the scar prevention observed in this small population coincides with the similar, potentially beneficial, findings of the same sealant material by Preul et al. (17) .
CONCLUSIONS
The synthetic, absorbable hydrogel sealant evaluated in this experiment was visible as imaged by CT scans and MRI throughout its absorption, which took place approximately 8 weeks after hydrogel implantation. The space occupied by the hydrogel closed after absorption of the gel, resulting in normal bone-flap healing. Histological examination 14 weeks after implantation found normal bone-flap healing, minimal scar formation between the bone flap and the dura, and no dura mater to pia mater attachments. In addition, the underlying cerebrum was normal, with no evidence of toxicity or of an adverse local effect. The outline of the cerebrum was normal, with no compressive alteration or evidence of a local mass effect. Mid-phase imaging performed at 2 to 4 weeks is expected to demonstrate adjoining enhancement on CT scans; if clinical concerns at this time point support differential consideration of an inflammatory process, MRI should be considered for further characterization of the implant.
